https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2001-12-01 / Cancer Res. 2001 Dec;61(23):8513-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2001-12-01 / Cancer Res. 2001 Dec;61(23):8513-92001-12-01 00:00:002019-02-15 08:53:19Vaccination of pediatric solid tumor patients with tumor lysate-pulsed dendritic cells can expand specific T cells and mediate tumor regression
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2001-12-01 / Cancer Res. 2001 Dec;61(23):8361-5
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2001-12-01 / Cancer Res. 2001 Dec;61(23):8361-52001-12-01 00:00:002001-12-01 00:00:00Heat shock and heat shock protein 70i enhance the oncolytic effect of replicative adenovirus
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2001-11-01 / Hepatology 2001 Nov;34(5):896-905
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2001-11-01 / Hepatology 2001 Nov;34(5):896-9052001-11-01 00:00:002019-02-15 09:13:28Effective treatment of small murine hepatocellular carcinoma by dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2001-11-01 / Exp. Hematol. 2001 Nov;29(11):1247-55
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2001-11-01 / Exp. Hematol. 2001 Nov;29(11):1247-552001-11-01 00:00:002001-11-01 00:00:00Dendritic cells in cancer vaccines
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2001-10-22 / Cancer Lett. 2001 Oct;172(1):27-36
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2001-10-22 / Cancer Lett. 2001 Oct;172(1):27-362001-10-22 00:00:002019-02-15 09:22:29Newcastle disease virus therapy of human tumor xenografts: antitumor effects of local or systemic administration
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2001-10-01 / J. Clin. Endocrinol. Metab. 2001 Oct;86(10):4965-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2001-10-01 / J. Clin. Endocrinol. Metab. 2001 Oct;86(10):4965-92001-10-01 00:00:002019-02-15 08:53:33Immunotherapy for medullary thyroid carcinoma by dendritic cell vaccination
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2001-09-01 / Eur. J. Cancer 2001 Sep;37(13):1599-608
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2001-09-01 / Eur. J. Cancer 2001 Sep;37(13):1599-6082001-09-01 00:00:002001-09-01 00:00:00Neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for locally advanced primary or recurrent high-risk adult soft-tissue sarcomas (STS) of adults: long-term results of a phase II study
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2001-09-01 / Cancer Immunol. Immunother. 2001 Sep;50(7):337-44
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2001-09-01 / Cancer Immunol. Immunother. 2001 Sep;50(7):337-442001-09-01 00:00:002019-02-15 08:47:02Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2001-09-01 / Cancer Res. 2001 Sep;61(17):6445-50
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2001-09-01 / Cancer Res. 2001 Sep;61(17):6445-502001-09-01 00:00:002019-02-15 09:23:53Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2001-09-01 / Int J Hyperthermia 2001 Sep-Oct;17(5):428-38
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2001-09-01 / Int J Hyperthermia 2001 Sep-Oct;17(5):428-382001-09-01 00:00:002001-09-01 00:00:00Effect of whole body hyperthermia on radiation therapy of transplanted fibrosarcoma in Swiss mice
